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Abstract
Background: To analyze the relationship of cocoa intake to central and peripheral blood pressure, arterial stiffness,
and carotid intima-media thickness in subjects with some cardiovascular risk factor.
Findings: Design: A cross-sectional study of 351 subjects (mean age 54.76 years, 62.4% males). Measurements:
Intake of cocoa and other foods using a food frequency questionnaire, central and peripheral (ambulatory and
office) blood pressure, central and peripheral augmentation index, pulse wave velocity, ambulatory arterial stiffness
index, carotid intima-media thickness, and ankle-brachial index.
Results: Higher pulse wave velocity and greater cardiovascular risk were found in non-cocoa consumers as
compared to high consumers (p < 0.05). In a multivariate analysis, these differences disappeared after adjusting for
age, gender, the presence of diabetes, systolic blood pressure and antihypertensive and lipid-lowering drug use. All
other arterial stiffness measures (central and peripheral augmentation index, ambulatory arterial stiffness index,
ankle-brachial index, and carotid intima-media thickness) showed no differences between the different
consumption groups.
Conclusions: In subjects with some cardiovascular risk factors, cocoa consumption does not imply improvement in
the arterial stiffness values.
Trial Registration: Clinical Trials.gov Identifier: NCT01325064.
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Introduction
Cocoa intake is related to a lower cardiovascular risk [1,2].
Although, two recently published metaanalyses coincide
that it is unclear whether cocoa consumption is related to
reductions in adverse cardiovascular outcomes [3,4].
The benefits of cocoa could be explained by an
improved endothelial function and a beneficial effect on
blood pressure [5], particularly in subjects with high
levels of blood pressure [6]. However, the relationship of
usual cocoa consumption to arterial stiffness parameters
and central blood pressure is not clear [7,8], although
cocoa intake has been related to a lower prevalence of
atherosclerotic plaques in carotid arteries [9,10]. The
relationship between cocoa consumption and arterial
stiffness has only been studied in healthy individuals
without cardiovascular risk factors.
The purpose of this study was to analyze the relation-
ship of cocoa intake to central and peripheral blood
pressure, arterial stiffness, and carotid intima-media
thickness in subjects with some cardiovascular risk
factor.
Methods
A cross-sectional study conducted on 351 subjects in a
primary care setting. Participants were recruited at pri-
mary care offices during 2010. Sample size was esti-
mated to detect a minimum difference of 1 m/sec in
pulse wave velocity (PWV) between two of the three
groups in which sample was divided based on cocoa
intake. Assuming an alpha risk of 0.05 and a beta risk of
0.2 in a two-sided test and a standard deviation of 2.1,
93 subjects per group were required, 279 in total. The
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Helsinki [11], and was approved by an independent
ethics committee of Salamanca University Hospital
(Spain). Written informed consent to participate in the
study was obtained from all subjects.
Information about the frequency of cocoa intake and
all other foods was collected using the food frequency
questionnaire of the University of Navarre, validated for
Spain [12]. This questionnaire categorizes cocoa con-
sumption as follows: Never, 1-3 servings/month, weekly,
2-4 servings/week, 5-6 servings/week, daily, 2-3 ser-
vings/day, 4-6 servings/day, more than 6 servings/day.
Cocoa intake was determined as follows: the average
daily consumption (weight) of cocoa-containing foods
and beverages was multiplied by their individual percen-
tage of cocoa contents, which were derived from food
labels and from published data. Cocoa intake from indi-
vidual foods was summed to yield the actual intake of
cocoa in grams per day for each subject. We posteriorly
divided the subjects according to estimated cocoa con-
sumption. Low cocoa consumption was taken to repre-
sent the intake of ≤ 1 serving/week.
Procedures for measuring office and ambulatory blood
pressure, ankle-brachial index (ABI), body mass index,
and abdominal waist circumference have been reported
in a prior publication [13].
Central blood pressure (CBP) and central and peripheral
augmentation index (CAIx, PAIx) were estimated using
the SphygmoCor System (AtCor Medical Pty Ltd., Head
Office, West Ryde, Australia). With the patient sitting and
t h ea r mr e s t i n go nar i g i ds u r f a c e ,p u l s ew a v ei nr a d i a l
artery was tested and used to estimate the aortic pulse
wave using a mathematic transformation. Inter-observer
reliability was assessed before the start of the study using
an intraclass correlation of 0.974 (95% CI: 0.936-0.989) in
repeated measures in 22 subjects and with Bland-Altman
analysis, where inter-observer agreement limits were 0.454
(95% CI: -9.876-10.785). Using the SphygmoCor System
(Vx pulse wave velocity), PWV was measured with the
patient in the supine position, estimating the delay in
pulse wave at carotid and femoral level as compared to the
electrocardiogram wave. Ambulatory arterial stiffness
index (AASI) is defined as 1 minus the regression slope of
24-hour diastolic on systolic blood pressure [14].
Carotid ultrasonography to assess intima-media thick-
ness of the common carotid artery (C-IMT) was per-
formed by two investigators specifically trained for that
purpose. A Sonosite Micromax ultrasound device (Sono-
site Inc., Bothell, Washington, USA) paired with a 5-10
MHz multifrequency high-resolution linear transducer
with Sonocal software was used for performing auto-
matic measurements of IMT, in order to optimize
reproducibility. Reliability of this measurement was eval-
uated before study start using intraclass correlation
coefficient, which showed values of 0.974 (95% CI:
0.935-0.990) for intra-observer agreement on repeated
measurements in 20 subjects, and 0.897 (95% CI: 0.740-
0.959) for inter-observer agreement. Six measurements
were taken on each carotid artery, using average values
(average IMT) and maximum values (maximum IMT)
calculated by the software automatically. Measurements
were taken following the recommendations of the Man-
heim Carotid Intima-Media Thickness Consensus [15].
Cardiovascular risk was estimated using the SCORE [16]
and D’Agostino [17] equations.
Continuous variables are expressed as the mean ±
standard deviation, and qualitative variables as frequency
distributions. Association between qualitative variables
was assessed using a Chi-square test, differences in
means between groups with an ANOVA test, and a
Scheffé test was used as a post hoc test with an alpha
v a l u e<0 . 0 5 .W eu s e dam u l t i v a r i a t ea n a l y s i sb a s e do n
the ANCOVA method (analysis of covariance), to com-
pare the arterial stiffness variables between different
cocoa-intake groups using as adjustment variables age,
gender, systolic blood pressure, diabetes and the pre-
sence of medical treatment (antihypertensive and lipid-
lowering drugs). SPSS/PC + version 18.0 statistical soft-
ware was used (SPSS Inc., Chicago, Illinois, USA).
Results
Sample consisted of 351 subjects (mean age 54.76 years,
62.4% males). Mean cocoa consumption of the global sam-
ple was 4.30 ± 9.08 g/day, with an intake among those
who consumed some cocoa of 7.74 ± 11.04 g/day, and a
median value of 2 g/day. Table 1 shows the clinical and
demographic characteristics of the population, as well as
measures of arterial stiffness, central and peripheral blood
pressure, C-IMT, and consumption of energy and immedi-
ate principles. Non-cocoa consumers had an older mean
age and a lower 24-hour diastolic blood pressure as com-
pared to the other groups, and also lower proportions of
diabetic and dyslipidemic patients (p < 0.05).
The proportion of patients treated with drugs was
greater among the non-consumers of cocoa than in the
high consumption group, referred to both the antihyper-
tensive agents (53.80% vs 37.80%) and the lipid-lowering
drugs (37.10% vs 15.70%). A higher proportion of males
(30.59%) as compared to females (16.67%) reported high
cocoa consumption.
PWV showed a significant difference between the
non-consumers (9.22 m/sec) and the high consumption
group (8.47 m/sec) (p = 0.039). However, in the multi-
variate analysis, on adjusting for age, gender, the pre-
sence of diabetes, systolic blood pressure and
antihypertensive and lipid-lowering drug use, this differ-
ence disappeared. The power of the contrast was 81%
for detecting differences in PWV between high
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Non-consumption
(n = 156)
Low consumption
≤ 1 serving/week
(n = 106)
High consumption
> 1 serving/week
(n = 89)
p
Age 57.32 ± 11.10 54.11 ± 11.76 51.07 ± 11.57 < 0.001
Male (n, %) 93 (59.60) 59 (55.70) 67 (75.30) 0.012
Female (n,%) 63 (40.40) 47(44.30) 22 (24.70) -
Diabetes (n, %) 58 (37.20) 23 (21.70) 8 (9.00) < 0.001
Hypertension (n, %) 126 (80.77) 83 (53.21) 64 (41.03) 0.273
Obesity (BMI > 30) (n, %) 58 (37.20) 36 (34.00) 20 (22.50) 0.057
Dyslipidemia (n, %) 109 (69.90) 84 (79.20) 75 (84.30) 0.034
Smoking (n, %) 35 (22.40) 27 (25.50) 23 (25.80) 0.783
Antihypertensive drugs (n, %) 84 (53.80) 48 (45.30) 33 (37.10) 0.037
Lipid lowering drugs (n, %) 59 (37.80) 27 (25.50) 14 (15.70) 0.001
BMI (Kg/m
2) 28.78 ± 4.61 28.46 ± 4.31 27.50 ± 3.74 0.082
Waist circumference (cm.) 98.21 ± 12.74 96.83 ± 11.44 95.93 ± 11.74 0.342
Serum glucose (mg/dL) 106.12 ± 36.32 95.42 ± 25.89 89.52 ± 15.74 < 0.001
Total cholesterol (mg/dL) 200.29 ± 40.16 205.41 ± 35.33 206.07 ± 34.59 0.400
Cardiovascular risk (Score) 5.08 ± 6.12 4.16 ± 7.06 2.82 ± 4.39 0.020
Cardiovascular risk (D’Agostino) 22.15 ± 15.60 18.68 ± 18.12 16.23 ± 13.66 0.017
Office SBP (mmHg) 138.81 ± 17.17 138.78 ± 17.86 140.12 ± 16.62 0.822
Office DBP (mmHg) 85.89 ± 10.74 87.09 ± 10.39 87.87 ± 11.27 0.357
Peripheral pulse pressure (mmHg) 52.91 ± 13.00 51.68 ± 13.01 52.24 ± 11.45 0.736
Central SBP (mmHg) 131.66 ± 18.35 130.58 ± 17.26 132.17 ± 19.09 0.820
Central DBP (mmHg) 87.87 ± 11.50 88.05 ± 10.78 89.49 ± 11.73 0.534
Central Pulse pressure (mmHg) 43.78 ± 14.12 42.53 ± 11.54 42.67 ± 12.76 0.696
24 h SBP (mmHg) 124.12 ± 12.48 125.73 ± 12.64 127.78 ± 12.39 0.087
24 h DBP (mmHg) 75.51 ± 9.52 77.47 ± 9.91 79.20 ± 9.35 0.014
24 h Pulse pressure (mmHg) 48.60 ± 9.70 48.26 ± 9.12 48.58 ± 9.26 0.955
PWV (m/s) 9.22 ± 2.15 8.93 ± 2.41 8.47 ± 1.96 0.039
C-IMT mean (mm.) 0.74 ± 0.10 0.72 ± 0.11 0.71 ± 0.13 0.109
C-IMT maximum (mm.) 0.91 ± 0.12 0.89 ± 0.13 0.88 ± 0.16 0.100
CAIx 30.24 ± 11.25 30.84 ± 11.34 28.81 ± 11.11 0.439
PAIx 94.74 ± 22.91 92.03 ± 17.95 88.43 ± 21.39 0.085
AASI 0.38 ± 0.06 0.37 ± 0.05 0.37 ± 0.05 0.331
Day AASI 0.38 ± 0.06 0.37 ± 0.05 0.37 ± 0.05 0.363
Night AASI 0.39 ± 0.14 0.37 ± 0.16 0.39 ± 0.16 0.786
ABI 1.07 ± 0.10 1.08 ± 0.11 1.08 ± 0.09 0.791
Total energy (Kcal/day) 2312.80 ± 691.41 2487.15 ± 660.39 2907.62 ± 777.29 < 0.001
Carbohydrates (g/day) 259.47 ± 95.26 269.97 ± 82.01 323.36 ± 99.28 < 0.001
Protein (g/day) 101.87 ± 32.40 108.73 ± 30.33 113.29 ± 28.44 0.016
Total fat (g/day) 87.35 ± 31.93 99.60 ± 36.93 120.11 ± 37.92 < 0.001
BMI: Body mass index, SBP: Systolic blood pressure, DBP: Diastolic blood pressure, IMT: Intima-media thickness, PWV: Pulse wave velocity, C-IMT: Carotid intima-
media thickness, CAIx: Central augmentation index, PAIx: Peripheral augmentation index, AASI: Ambulatory arterial stiffness index, ABI: ankle-brachial index
Data for qualitative variables are expressed as n (%) and quantitative variables as mean ± standard deviation
p: statistically significant differences (p < 0.05)
Recio-Rodríguez et al. Nutrition Journal 2012, 11:8
http://www.nutritionj.com/content/11/1/8
Page 3 of 5consumers and non-consumers, and 42% between high
consumers and low consumers. All other arterial stiff-
ness measures showed no differences between the differ-
ent consumption groups (Figure 1).
We re-analyzed the data, excluding the diabetics, with-
out any modification of the results or conclusions
obtained.
Discussion
Although there was a trend to a decreased arterial stiff-
ness as cocoa consumption increased, data collected
show that cocoa intake had no influence on arterial stiff-
ness or C-IMT measurements, or on central and periph-
eral blood pressure values, in subjects with some
cardiovascular risk factors.
Vlachopoulos et al. [7], found that regular cocoa
intake is related to decreased aortic stiffness and
improved central hemodynamics. In their study popula-
tion, the mean cocoa intake in healthy individuals was
4.63 g/day. Similar amount in terms of cocoa-intake to
those obtained in our study (4.30 g /day). The inconsis-
tency between this study and our findings merits
comments. While subjects in the previous trial were
healthy, our study included subjects with some cardio-
vascular risk factor (hypertension, diabetes, or dyslipide-
mia). These risk factors can influence the measures used
to estimate arterial stiffness. In addition, many of the
patients were receiving antihypertensive medication and
lipid-lowering drugs, which may influence the results
obtained. However, the interest of the study is that no
previous evaluations have been made of the relationship
between cocoa consumption and arterial stiffness in
subjects of this kind.
However, data found in our population were similar to
those collected by Ried K et al. [6], who concluded that
cocoa was superior to placebo for reducing blood pres-
sure in prehypertension. In the van den Bogaard B et al.
study [8], cocoa increased 24-hour mean blood pressure
and PWV, but decreased central systolic blood pressure
and augmentation index. Thus, these authors did not
also find a consistent relationship between cocoa intake
and blood pressure and arterial stiffness measurements.
Djousse L and Lewis JR [9,10], recorded a inversely
association between cocoa consumption and carotid
Figure 1 Multivariate analysis (ANCOVA). Box plots of PWV, AASI, C-IMT, and PAIx in the different cocoa consumption groups. Mean (95% CI)
adjusted for age, gender, the presence of diabetes, systolic blood pressure and antihypertensive and lipid-lowering drug use.
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dence of our study, no significant relationship was
found between C-IMT and cocoa intake. There are sev-
eral possible explanations for this results. In our study,
the three groups of cocoa-intake are very heterogenous
with differences in age, gender and the proportion of
subjects with antihypertensive and lipid-lowering drugs.
This fact may influence the results.
A limitation of the study is the statistical power
because may not be sufficient to detect differences
between cocoa-intake groups that could really exist in
the population.
Conclusions
In conclusion, in subjects with some cardiovascular risk
factors, cocoa consumption does not imply improve-
ment in the arterial stiffness values. However, further
studies specifically designed to test the relationship are
needed.
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